The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kim I.V.

FBGU "Éndokrinologicheskiĭ nauchnyĭ tsentr" Minzdravsotsrazvitiia Rossii, Moskva

Bochkareva E.V.

National Medical Research Center of Preventive Medicine, Moscow, Russia

Varakin Yu.Ya.

Research Center of Neurology, Russian Academy of Sciences, Moscow

Cerebrovascular disease screening in general medical practice: methodological aspects

Authors:

Kim I.V., Bochkareva E.V., Varakin Yu.Ya.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2017;20(5): 59‑64

Read: 1135 times


To cite this article:

Kim IV, Bochkareva EV, Varakin YuYa. Cerebrovascular disease screening in general medical practice: methodological aspects. Russian Journal of Preventive Medicine. 2017;20(5):59‑64. (In Russ.)
https://doi.org/10.17116/profmed201720559-64

Recommended articles:
The significance of exogenous nitrate and nitrite of plant origin for vascular health. Russian Journal of Preventive Medi­cine. 2024;(11):141-146
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124

References:

  1. The Demographic Yearbook of Russia. 2015: Statistical Handbook/Rosstat. M. 2015. (In Russ.) Available at: http://www.gks.ru/free_doc/doc_2015/demo15.pdf Accessed april 27, 2017
  2. Public health in Russia. 2015. Statistical collection. Rosstat. М. 2015. (In Russ.) Available at: http://www.gks.ru/free_doc/doc_2015/zdrav15.pdf Accessed april 27, 2017
  3. Suslina ZA, Varakin YuYa. Clinical guidelines for the early diagnosis, treatment and prevention of vascular diseases of the brain. M. 2015. (In Russ.)
  4. Shmidt EV. The classification of cerebral and spinal vascular diseases. Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 1985;9:1281-1288. (In Russ.)
  5. Varakin YuYa. Epidemiological aspects of prevention of cerebral circulation disorders. Atmosfera. Nervnye bolezni. 2005;2:4-10. (In Russ.)
  6. Varakin YuYa, Gnedovskaya EV, Andreeva OS, et al. Clinical and pathogenetic aspects of hypertension crisis in patients with initial symptoms of chronic cerebrovascular disease. Annaly nevrologii. 2014;8(2):16-20. (In Russ.)
  7. Kokurina EV, Varakin YuYa, Koltunov IE. Active identification and treatment of coronary heart disease and cerebrovascular diseases in practical health care. M. 2009. (In Russ.)
  8. Kim IV, Bochkareva EV, Varakin YuYa, et al. Main results of screening methodology to reveal cardio- and cerebrovascular pathology in primary outpatient care. Kardiovaskulyarnaya terapiya i profilaktika. 2014;3(3):25-31. (In Russ.) https://doi.org/10.15829/1728-8800-2014-3-25-31
  9. Rose G. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 1962;27:645-658.
  10. Varakin YuYa, Oshchepkova EV, Gornostayeva GV, et al. Impact of antihypertensive therapy on clinical status and quality of life in patients with initial manifestations of hypertensive encephalopathy. Terapevticheskii arkhiv. 2010;82(12):10-15. (In Russ.)
  11. Chen GJ, Yang MS. The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials. Plos One. 2013;8(3). https://doi.org/10.1371/journal.pone.0057854
  12. Dahlof B, Devereux RB, Kjeldsen SE, et al, for the LIFE study group. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet. 2002;359(9311):995-1003. https://doi.org/10.1016/S0140-6736(02)08089-3
  13. Wiysonge CS, Bradley HA, Volmink J, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2012;8:CD002003. https://doi.org/10.1002/14651858.CD002003.pub2
  14. European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal 2016;37:2315-2381. https://doi.org/10.1093/eurheartj/ehw106
  15. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. https://doi.org/10.1136/bmj.b1665
  16. Guidelines for the Primary Prevention of Stroke A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2014;45:00-00. https://doi.org/10.1161/STR.0000000000000046
  17. ESH/ESC Guidelines for the management of arterial hypertension. European Heart Journal. 2013;34:2159-2219. https://doi.org/10.1093/eurheartj/eht151
  18. Rizos CV, Elisaf MS. Antihypertensive drugs and glucose metabolism. World J Cardiol. 2014;6(7):517-530. https://doi.org/10.4330/wjc.v6.i7.517
  19. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005;18(2):CD000269. https://doi.org/10.1002/14651858.CD000269.pub3
  20. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis. 2008;25:457-507. https://doi.org/10.1159/000131083
  21. Alvarez-Sabín J, Roman GC. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke. 2011;42:(suppl 1):S40-S43. https://doi.org/10.1161/STROKEAHA.110.606509
  22. Shishkova VN. Place of arterial hypertension in brain lesion development – from minor cognitive disorders to dementia. Sistemnye gipertenzii. 2014;1:45-51. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.